Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Acromegaly Treatment Market: By Product: Somatostatin Analogs (SSA), Growth Hormone Receptor Antagonist (GHRA), Others; By End Use: Hospitals, Clinics, Others; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Acromegaly Treatment Market Outlook

The global market for acromegaly treatment reached a value of about USD 1.50 billion in 2021. The market is further expected to grow at a CAGR of about 7.6% in the forecast period of 2022-2027 to reach a value of around USD 2.33 billion by 2027.

 

North America is Expected to Lead the Market for Acromegaly Treatment

North America, owing to the high demand for novel prescriptions, innovative products, and the presence of established players in the market, is expected to be the leading region for acromegaly treatment. The United States and Canada are the largest markets for acromegaly treatment; due to the growing population prevalence of the disease, the medical institutes are spreading awareness of treatments with the government introducing favourable policies. Furthermore, the rise in collaborations and effort in research and development by the established organisations to develop new products and innovative procedures are propelling the demand for treatment, which in turn, helps in market growth.

 

Asia Pacific is Proliferating with the Increased Funding for Healthcare

Asia Pacific is showing promising growth opportunities for the market. The region is going through industrialisation, and people are increasingly moving to urban areas seeking a better lifestyle, which shows the rising awareness among people. The government is increasing their healthcare expenditure to establish an improved infrastructure, and with development in various sectors, the spending power of people will simultaneously increase, which will further drive the market growth.

 

Market Segmentations

Acromegaly is a hormonal disorder that develops in the pituitary gland, which increases growth hormone production. A non-cancerous tumour usually causes it. In acromegaly treatment, the goal is to restore the pituitary gland to function normally and produce normal levels of growth hormone.

By product, the market for acromegaly treatment includes:

  • Somatostatin Analogs (SSA)
  • Growth Hormone Receptor Antagonist (GHRA)
  • Others

The end-uses of the acromegaly treatment include:

  • Hospitals
  • Clinics 
  • Others

The regional markets for acromegaly treatment can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa, with North America leading the market and Asia Pacific being the fastest-growing region.

 

Rising Prevalence of Diseases and New Medications Bolstering the Market Growth

As the population rises, the number of patients is increasing, and to provide safe and sufficient services, and the healthcare infrastructure is being developed continuously. Advancements in surgery and innovative alternate techniques are further broadening the market limits. The high cost of surgery can pose a little setback to market growth. However, governments are introducing favourable policies to spread medical treatment awareness. Multiple medical institutes and organisations are focusing on research and development to introduce novel medications, such as somatostatin analogs, which help stop the excess production of growth hormones. Additionally, with the launch of technologically advanced detection techniques like radiosurgery, radio imaging technologies provide cost-effective options for diagnosis with minimum side effects.

 

Key Players in the Global Market for Acromegaly Treatment

The report gives a detailed analysis of the following key players in the global acromegaly treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, investments, expansions of capacity, and plant turnarounds:

  • Novartis AG      
  • Ipsen Biopharmaceuticals, Inc.
  • Chiasma, Inc.
  • Pfizer Inc. 
  • Ionis Pharmaceuticals, Inc. 
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • End Use
  • Region
Breakup by Product
  • Somatostatin Analogs (SSA)
  • Growth Hormone Receptor Antagonist (GHRA)
  • Others
Breakup by End Use
  • Hospitals
  • Clinics 
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Novartis AG      
  • Ipsen Biopharmaceuticals, Inc.
  • Chiasma, Inc.
  • Pfizer Inc. 
  • Ionis Pharmaceuticals, Inc. 
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Acromegaly Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Acromegaly Treatment Historical Market (2017-2021) 
    8.3    Global Acromegaly Treatment Market Forecast (2022-2027)
    8.4    Global Acromegaly Treatment Market by Product 
        8.4.1    Somatostatin Analogs (SSA) 
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Growth Hormone Receptor Antagonist (GHRA)
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Others
    8.5    Global Acromegaly Treatment Market by End Use
        8.5.1    Hospitals
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Clinics 
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Others
    8.6    Global Acromegaly Treatment Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Novartis AG    
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Ipsen Biopharmaceuticals, Inc.
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Chiasma, Inc.
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Pfizer Inc. 
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    Ionis Pharmaceuticals, Inc. 
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Others
12    Industry Events and Developments

 

List of Key Figures and Tables

1.    Global Acromegaly Treatment Market: Key Industry Highlights, 2017 and 2027
2.    Global Acromegaly Treatment Historical Market: Breakup by Product (USD Billion), 2017-2021
3.    Global Acromegaly Treatment Market Forecast: Breakup by Product (USD Billion), 2022-2027
4.    Global Acromegaly Treatment Historical Market: Breakup by End Use (USD Billion), 2017-2021
5.    Global Acromegaly Treatment Market Forecast: Breakup by End Use (USD Billion), 2022-2027
6.    Global Acromegaly Treatment Historical Market: Breakup by Region (USD Billion), 2017-2021
7.    Global Acromegaly Treatment Market Forecast: Breakup by Region (USD Billion), 2022-2027
8.    North America Acromegaly Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
9.    North America Acromegaly Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
10.    Europe Acromegaly Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
11.    Europe Acromegaly Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
12.    Asia Pacific Acromegaly Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    Asia Pacific Acromegaly Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Latin America Acromegaly Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Latin America Acromegaly Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Middle East and Africa Acromegaly Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Middle East and Africa Acromegaly Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Global Acromegaly Treatment Market Structure

Key Questions Answered in the Report

In 2021, the global market for acromegaly treatment attained a value of nearly USD 1.50 billion.

The market is projected to grow at a CAGR of 7.6% between 2022 and 2027.

The market is estimated to witness healthy growth in the forecast period of 2022-2027 to reach USD 2.33 billion by 2027.

The increasing prevalence of diseases among the growing population, technological advancements, and increasing investment in healthcare are the major industry drivers.

The players' key industry trends are technological advancements and favourable government policies to reduce treatment expenses.

The major regions in the industry are North America, Latin America, the Middle East, Africa, Europe, and the Asia Pacific, with North America being the leading region in the market and Asia Pacific growing at an exponential rate.

The different products in the market include somatostatin analogs (SSA) and growth hormone receptor antagonist (GHRA), among others.

The end-users for acromegaly treatment in the market include Hospitals and Clinics, among others.

The major players in the industry are Novartis AG, Ipsen Biopharmaceuticals, Inc., Chiasma, Inc., Pfizer Inc., and Ionis Pharmaceuticals, Inc., among others.

Analyst Review

The global acromegaly treatment market attained a value of USD 1.50 billion in 2021, driven by the rising prevalence of diseases among the growing population. Aided by the ever-increasing technological advancements and launch of novel medications, the market is expected to witness further growth in the forecast period of 2022-2027, growing at a CAGR of 7.6%. The market is projected to reach USD 2.33 billion by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its products, the market can be segmented into somatostatin analogs (SSA) and growth hormone receptor antagonist (GHRA), among others. The treatment finds end-uses in hospitals and clinics, among others. The major regional markets for xx are North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, with North America establishing itself as the largest market region and Asia Pacific showing the most growth opportunities. The key players in the above market include Novartis AG, Ipsen Biopharmaceuticals, Inc., Chiasma, Inc., Pfizer Inc., and Ionis Pharmaceuticals, Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER